Robert Stanard v. Maria Dy

88 F.4th 811
CourtCourt of Appeals for the Ninth Circuit
DecidedDecember 11, 2023
Docket21-35582
StatusPublished
Cited by17 cases

This text of 88 F.4th 811 (Robert Stanard v. Maria Dy) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Robert Stanard v. Maria Dy, 88 F.4th 811 (9th Cir. 2023).

Opinion

FOR PUBLICATION

UNITED STATES COURT OF APPEALS FOR THE NINTH CIRCUIT

ROBERT A. STANARD, AKA No. 21-35582 Robert Allen Stanard, D.C. No. 2:19-cv- Plaintiff-Appellant, 01400-RSM

v. OPINION MARIA DY, Doctor, FDC SeaTac; DAN SPROUL, Warden, FDC SeaTac; K. MARTINEZ, Physician's Assistant, FDC SeaTac; MARY MITCHELL, Western Regional Director; IAN CONNERS, Administrator, National Inmate Appeals; LEEN, Health Services Administrator, FCI Sheridan; J. BALTAZAR, Western Regional Director; UNKNOWN PARTY, Medical Director of the FBOP; UNKNOWN PARTY, Regional Medical Director; MCDERMONT, Health Services Administrator, FDC SeaTac,

Defendants-Appellees. 2 STANARD V. DY

Appeal from the United States District Court for the Western District of Washington Ricardo S. Martinez, District Judge, Presiding

Argued and Submitted March 30, 2023 Seattle, Washington

Filed December 11, 2023

Before: Jacqueline H. Nguyen and Andrew D. Hurwitz, Circuit Judges, and Dean D. Pregerson,* District Judge.

Opinion by Judge Pregerson

SUMMARY**

Prisoner Civil Rights/Bivens

In a Bivens action brought by Robert Stanard alleging that federal prison officials denied him treatment for Hepatitis C, the panel reversed the district court’s dismissal of his claim that federal prison officials were deliberately indifferent to his medical needs in violation of the Eighth Amendment, and affirmed the district court’s dismissal of his claim that federal prison officials discriminated against

* The Honorable Dean D. Pregerson, United States District Judge for the Central District of California, sitting by designation. ** This summary constitutes no part of the opinion of the court. It has been prepared by court staff for the convenience of the reader. STANARD V. DY 3

him in denying him treatment because of his pre-trial status in violation of the Fifth Amendment Due Process Clause. The panel reversed the district court’s dismissal of Stanard’s Eighth Amendment medical indifference claim. The panel held that the claim arose within an existing context as established in Carlson v. Green, 446 U.S. 14 (1980), which recognized a Bivens remedy against prison officials who were deliberately indifferent to an inmate’s asthma. The panel rejected defendants’ argument that Carlson was meaningfully different because the officials in Carlson acted so inappropriately as to evidence intentional maltreatment causing death, while the officials here denied Stanard care because of a Bureau of Prisons (“BOP”) policy. Delaying treatment is an established example of deliberate indifference to a serious medical need, in violation of the Eighth Amendment. Even assuming Stanard received less deficient care than the inmate in Carlson, that difference in degree was not a meaningful difference giving rise to a new context. Moreover, Stanard was not simply challenging a broadly applicable BOP policy. His complaint alleged, among other things, that defendants relied on outdated medical records in refusing him treatment for Hepatitis C. The panel affirmed the district court’s dismissal of Stanard’s Fifth Amendment claim. The panel held that the claim arose in a new context and special factors counseled hesitation against extending Bivens given that alternative remedial structures existed. 4 STANARD V. DY

COUNSEL

Xiao Wang (argued), Assistant Professor of Law, University of Virginia Law School, Charlottesville, Virginia; Matthew Dickel, Taylor Hoffman, Elisabeth Logan, and Briana Singson, Certified Law Students, Northwestern University Pritzker School of Law Appellate Advocacy Center, Bluhm Legal Clinic, Chicago, Illinois; Samuel Weiss, Founder and Executive Director; Oren Nimni, Litigation Director; Rights Behind Bars, Washington, D.C.; for Petitioner-Appellant. Tania M. Culbertson (argued) and Matt Waldrop, Assistant United States Attorneys; Nicholas W. Brown, United States Attorney, Western District of Washington, United States Attorney’s Office, Seattle, Washington; for Defendants- Appellees.

OPINION

PREGERSON, District Judge:

Robert A. Stanard claims in this action that his Fifth and Eighth Amendment rights were violated by various federal prison officials when he was denied treatment for Hepatitis C. The district court dismissed Stanard’s pro se complaint, finding that it failed to state a Bivens claim. See Bivens v. Six Unknown Named Agents of Fed. Bureau of Narcotics, 403 U.S. 388 (1971). We affirm as to Stanard’s Fifth Amendment claim and reverse as to his Eighth Amendment claim. STANARD V. DY 5

I. FACTUAL BACKGROUND1 Stanard contracted Hepatitis C Virus (“HCV”) at a Bureau of Prisons (“BOP”) facility in 2009. In November 2016, Stanard was arrested for being a felon in possession of a firearm and detained at Federal Detention Center SeaTac pending trial. Stanard declined HCV treatment during his first meeting with Dr. Maria Dy at SeaTac because he was suffering from a mental health crisis and, in his own words, “just wanted to die.” In January 2018, Stanard was found guilty of firearm possession and related charges. In February or March 2018, while still at SeaTac pending sentencing, Stanard started to seek treatment for HCV. He met with Dr. Dy again, who told him that he was “not qualified” for treatment at the time, based on his January 2 AST (“aspartate aminotransferase”)- to-platelet ratio index (“APRI”) of 0.41.2 On March 2, Stanard submitted a BP-8, a Bureau of Prisons informal complaint form, requesting HCV treatment. He did not receive a response. When Stanard followed up with his counselor, he was told to fill out another BP-8. Stanard submitted the second BP-8 on April 3. His counselor responded on May 13, rejecting Stanard’s request for treatment because he was “treatment Priority Level 3 and a pre-trial inmate[.] [BOP] is currently focusing on treating

1 Because this is an appeal from an order granting a motion to dismiss, we assume the truth of the facts alleged in the complaint. See Pettibone v. Russell, 59 F.4th 449, 450–51 (9th Cir. 2023). 2 In November 2017, Stanard’s APRI was 0.6. It later rose to 2.51 but went back down to 0.41 by January 2, 2018. A higher APRI generally corresponds to more advanced or severe HCV complications. An APRI above 2.0 is indicative of advanced liver damage. 6 STANARD V. DY

designated Priority 1&2 Level inmates. You will continue to be monitored accordingly.” Stanard began the formal complaint process by filing a BP-9 form (“Request for Administrative Remedy”) on May 15. Stanard complained of abdominal pain. He had just witnessed the decline and death of a fellow inmate from untreated HCV, and was worried that “without a valid course of treatment I will die at a much quicker rate than normal[].” The Warden denied Stanard’s BP-9 request on May 22, noting that Stanard was “treatment Priority Level 3 and a pre-trial inmate.” On May 30, 2018, Stanard appealed the Warden’s decision by filing a BP-10 (“Regional Administrative Remedy Appeal Form”) with the regional medical director. On September 28, before receiving a response to his appeal, Stanard was transferred to Federal Correctional Institution (“FCI”) Sheridan. Because he had not received a response to his BP-10, Stanard filed a BP-11 (“Central Office Administrative Remedy Appeal Form”) on October 7, 2018. He saw a doctor at FCI Sheridan on November 19, and again requested HCV treatment. The doctor told Stanard he would receive HCV treatment after “a short wait.” Responses to Stanard’s BP-10 and BP-11 forms came on December 6 and November 13, respectively.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
88 F.4th 811, Counsel Stack Legal Research, https://law.counselstack.com/opinion/robert-stanard-v-maria-dy-ca9-2023.